Ignite Creation Date:
2024-05-06 @ 1:33 PM
Last Modification Date:
2024-10-26 @ 1:16 PM
Study NCT ID:
NCT04059081
Status:
UNKNOWN
Last Update Posted:
2019-08-16
First Post:
2019-08-15
Brief Title:
A Prospective Cohort of Obinutuzumab and Chlorambucil GC Chemotherapy for the Treatment of Elderly Patients With Chronic Lymphocytic Leukemia Including Next- Generation Sequencing NGS-Based Assessment
Sponsor:
Deok-Hwan Yang
Organization:
Chonnam National University Hospital
Study Overview
Official Title:
A Prospective Cohort of Obinutuzumab and Chlorambucil GC Chemotherapy for the Treatment of Elderly Patients With Chronic Lymphocytic Leukemia Including Next- Generation Sequencing NGS-Based Assessment
Status:
UNKNOWN
Status Verified Date:
2019-08
Last Known Status:
RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study is prospective open-label single arm observational study to assess efficacy of obinutuzumab plus chlorambucil GC chemotherapy in treatment naïve CLL and prognostic impact of genetic alterations for CLL using NGS
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None